19-11-2026 15:00 via Nachrichten Ticker - Kategorie: Analysen - www.wallstreet-online.de

Lexaria's Human Study GLP-1-H26-7 Completes Dosing as Scheduled

KELOWNA, BC / ACCESS Newswire / November 19, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, reports that final dosing has been completed on schedule with Human Pilot Study …
Weiterlesen »